News
2mon
GlobalData on MSNFDA approves drug application for Lupin’s heart failure therapyThe US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Entresto 800mg/200mL oral suspension can be prepared in a concentration of 4mg/mL (sacubitril/valsartan 1.96/2.04mg/mL). Use Entresto 49/51mg tablets in the preparation of the suspension.
Hosted on MSN10mon
Alembic Pharma Gets USFDA Nod To Market Heart Failure DrugThe company has received final approval from the US Food & Drug Administration (USFDA) for Sacubitril and Valsartan Tablets in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg, Alembic said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results